Glomerular protein trafficking and progression of renal disease to terminal uremia

Seminars in Nephrology

Volumn 16, Issue 3, 1996, Pages 151-159

  Benigni, Ariela ^a   Remuzzi, Giuseppe ^b  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; PROTEIN;

BASOLATERAL MEMBRANE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLOMERULUS FILTRATION; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY INTERSTITIUM; KIDNEY TUBULE ABSORPTION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; PROTEIN URINE LEVEL; PROTEINURIA; REVIEW; SIGNAL TRANSDUCTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CHEMOKINE CCL2; ENDOTHELINS; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES; PROTEINS; UREMIA;

EID: 0029985360     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Myers BD, Guasch A: Mechanisms of massive protein-uria. J Nephrol 7:254-260, 1994
2. Shemesh O, Deen WM, Brenner BM, et al: Effect of colloid volume expansion on glomerular barrier size-selectivity in humans. Kidney Int 29:916-923, 1986
3. Yoshioka T, Rennke HG, Salant DJ, et al: Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: A study in early passive Heymann nephritis. Circ Res 61:531-538, 1987
4. Bertani T, Cutillo F, Zoja C, et al: Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 30:488-496, 1986
5. Bertani T, Zoja C, Abbate M, et al: Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein contents. Lab Invest 60:196-204, 1989
6. Maack T, Park CH, Camargo MJF: Renal filtration, transport, and metabolism of proteins, in Seidin DW, Giebisch G (eds): The Kidney: Physiology and Pathophysiology. New York, NY, Raven Press, 1985, pp 1773-1803
7. Schreiner GF: Renal toxicity of albumin and other lipoproteins. Curr Opin Nephrol Hypertens 4:369-373, 1995
8. Saxton JA Jr, Kimball JC: Relation of nephrosis and diseases of albino rat to age to modification of diet. Arch Pathol 32:951-955, 1941
9. Blatherwick NR, Medlar EM: Chronic nephritis in rats fed high protein diets. Arch Intern Med 59:572-596, 1937
10. Berg BN, Simms HS: Nutrition and longeity in the rat. II. Longevity and onset of disease with different levels of food intake. J Nutr 71:255-258, 1960
11. Johnson JE, Barrows CH: Effects of age and dietary restrictions on the kidney glomeruli of mice: Observation by scanning electron microscopy. Anat Rec 196:145-149, 1980
12. Tucker SM, Mason RL, Beauchene RE: Influence of diet and food restriction on kidney function of aging male rats. J Gerontol 31:264-269, 1976
13. Remuzzi A, Puntorieri S, Mazzoleni A, Remuzzi G: Sex-related differences in glomerular ultrafiltration and proteinuria in Munich-Wistar rats. Kidney Int 34:481-486, 1988
14. Remuzzi A, Puntorieri S, Battaglia C, et al: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85:541-549, 1990
15. Zatz R, Dunn BR, Meyer TW, et al: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
16. Remuzzi A, Perico N, Amuchastegui CS, et al: Short-and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 4:40-49, 1993
17. Nakamura T, Kimura H, Obata J, et al: Angiotensin II (Ang. II) blockade prevents the progression of experimental mesangial proliferative nephritis in rats. J Am Soc Nephrol 6:879, 1995 (abstr)
18. Eddy AA: Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 135:719-733, 1989
19. Anderson MS, Recant L: Fine structural alterations in the rat kidney following intraperitoneal bovine albumin. Am J Pathol 40:555-569, 1962
20. Fisher ER, Hellstrom HR: Mechanism of proteinuria: Functional and ultrastructural correlation of effects of infusion of homologous and heterologous protein (bovine serum albumin) in the rat. Lab Invest 11:617-637, 1962
21. Davies DJ, Messina A, Thumwood CM, Ryan GB: Glomerular podocytic injury in protein overload proteinuria. Pathology 17:412-419, 1985
22. Weening JJ, Van Guldener C, Daha MR, et al: The pathophysiology of protein-overload proteinuria. J Nephrol 1987
23. Mori H, Yamashita H, Nakanishi C, et al: Proteinuria induced by transplantable rat pituitary tumor MtT SA5. Model for homologous protein overload proteinuria. Lab Invest 54:636-644, 1986
24. Eddy AA, McCulIoch L, Liu E, Adams J: A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol 138:1111-1123, 1991
25. Magil AB: Tubulointerstitial lesions in young Zucker rats. Am J Kidney Dis 25:478-485, 1995
26. Croker BP, Dawson DV, Sanfilippo F: IgA nephropathy. Correlation of clinical and histologie features. Lab Invest 48:19-24, 1983
27. Widstam-Attorps U, Berg U, Bohman SO, Lefvert AK: Proteinuria and renal function in relation to renal morphology. Clin Nephrol 38:245-253, 1992
28. Okada K, Funai M, Kawakami K, et al: IgA nephropathy Japanese children and adults: A comparative study of clinicopathological features. Am J Nephrol 10:191-197, 1990
29. Mauer SM, Steffes MW, Ellis EN, et al: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
30. Magil AB: Tubulointerstitial lesions in human membranous glomerulonephritis: Relationship to proteinuria. Am J Kidney Dis 25:375-379, 1995
31. Wehrmann M, Bohle A, Bogenschutz O, et al: Long-term prognosis of chronic idiopathic membranous glomerulonephritis. Clin Nephrol 31:67-76, 1989
32. Detwiler RK, Falk RJ, Mogan SL, Gennette JC: Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416-1424, 1994
33. Lane PM, Steffes MW, Fioretto P, Mauer SM: Renal interstitial expansion in insulin dependent diabetes mellitus. Kidney Int 43:661-667, 1993
34. Schmitt M, Bohle A, Reineke T, et al: Long-term prognosis of membranoproliferative glomerulonephritis type 1. Significance of clinical and morphological parameters: An investigation of 220 cases. Nephron 55:242-250, 1990
35. Donadio JV, Bergstralh EJ, Offord KP, et al: Clinical and histopathologic associations with impaired renal function in IgA nephropathy. Clin Nephrol 41:65-71, 1994
36. Zoja C, Remuzzi A, Corna D, et al: Renal protective effect of angiotensin-converting enzyme inhibition in aging rats. Am J Med 92:60S-63S, 1992
37. Perico N, Amuchastegui CS, Malanchini B, et al: Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage. Exp Nephrol 2:220-228, 1994
38. Zoja C, Corna D, Bruzzi I, et al: Passive Heymann nephritis: Evidence that angiotensin converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Nephrol 1995 (in press)
39. Bawer JH: Diabetic nephropathy: Can it be prevented? Are there renal protective antihypertensive drugs of choice? South Med J 87:1043-1053, 1994
40. Parving H-H, Andersen AR, Hommel E, Smidt U: Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension 7:114-117, 1985 (suppl II)
41. Parving H-H, Andersen AR, Smidt U, et al: Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294:1443-1447, 1987
42. Parving H-H, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin-dependent diabetes with nephropathy. Br Med J 297:1086-1091, 1988
43. Kasiske BL, Kalil RSN, Jennie Z, et al: Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118:129-138, 1993
44. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
45. Alvestrand A, Gutierrez A, Bucht M, Bergstrom J: Reduction of blood pressure retards the progression of chronic renal failure in man. Nephrol Dial Transplant 3:624-631, 1988
46. Apperloo AJ, de Zeeuw D, de Joug PB: The initial antiproteinuric effect of antihypertensive treatment predicts the effect of treatment on long-term renal function outcome. J Am Soc Nephrol 3:279(A), 1992
47. Praga M, Hernandez E, Montoyo C, et al: Long term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20:240-248, 1992
48. Hannedouche T, Laudais P, Goldfarb B, et al: Randomized controlled trial of enalapril and β blockers in nondiabetic chronic renal failure. Br Med J 309:833-837, 1994
49. Klahr S, Levey AS, Beck GJ, et al: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
50. El-Nahas AM, Masters-Thomas A, Brady SA, et al: Selective effect of low protein diets in chronic renal diseases. Br Med J 289:1337-1341, 1984
51. Aparicio M, Potaux L, Bouchet JL, et al: Proteinuria and progression of renal failure in patients on a low-protein diet. Nephron 51:292-293, 1989
52. 13α in OK cells. J Am Soc Nephrol 6:373, 1995 (abstr)
53. Thakkar H, Newman DJ, Burrin JM: Cytotoxic effects of human serum albumin on cultured human proximal tubular cells. J Am Soc Nephrol 6:887, 1995 (abstr)
54. Peruzzi L, Amore A, Trusolino L, et al: Tubulo-interstitial messages in the progression of glomerular diseases: Albuminuria modulates integrin expression on cultured tubular cells. J Am Soc Nephrol 6:906, 1995 (abstr)
55. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9:617-648, 1991
56. Taub DD, Proost P, Murphy WJ, et al: Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 95:1370-1376, 1995
57. Harris DCH, Chen J: Monocyte chemoattractant protein-1 (MCP-1) mRNA expression in response to protein in rat proximal tubule cells in culture. J Am Soc Nephrol 6:1015, 1995 (abstr)
58. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47:1546-1557, 1995
59. Butler WT: The nature and significance of osteopontin. Connect Tissue Res 23:123-136, 1989
60. Pichler R, Giachelli CM, Lombardi D, et al: Tubulointerstitial disease in glomerulonephritis. Am J Pathol 144:915-926, 1994
61. Kohan DE: Endothelin synthesis by rat tubule cells. Am J Physiol 261:F221-F226, 1991
62. Zeidel M, Brady H, Kone B, Gullans S, Brenner B: Endothelin, a peptide inhibitor of Na+/K+-ATPase in intact renal tubular epithelial cells. Am J Physiol 257:C1101-C1107, 1989
63. Oishi R, Nonoguchi H, Tomita K, Marumo F: Endothelin-1 inhibits AVP-stimulated osmotic water permeability inner medullary collecting duct. Am J Physiol 261:F951-F956, 1991
64. Kohan DE, Padilla E: Endothelin-1 is an autocrine factor in rat inner medullary collecting ducts. Am J Physiol 32:F607-F612, 1992
65. Zoja C, Morigi M, Figliuzzi M, et al: Proximal tubular cell synthesis and secretion of endothelin-1 upon challenge with albumin and other proteins. Am J Kidney Dis (in press)
66. Ong ACM, Jowett TP, Firth JD, et al: A new paracrine loop implicated in human tubulo-interstitial fibrosis: Tubularderived endothelins modulate renal interstitial fibroblast function. J Am Soc Nephrol 4:473, 1993 (abstr)
67. Chen XM, Yu LF, Zeng Q: Production of endothelin (ET-1) in kidney tubular cell (LLC-PK1) induced by extracellular matrix (ECM). ISN Madrid (Spain), July 2-6, Theme, VII:299, 1995 (abstr)
68. Achmad T, Rao G: Chemotaxis of human blood monocytes towards endothelin-1 and the influence of calcium channel blockers. Biochem Biophys Res Commun 189:994-1000, 1992
69. Helset E, Sildnes T, Seljelid R, Konopski ZS: Endothelin-1 stimulates human monocytes in vitro to release TNFa, IL-1b and IL-6. Mediators Inflammation 2:417-422, 1993
70. Orisio S, Benigni A, Bruzzi I, et al: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 43:354-358, 1993
71. Nakamura T, Ebihara I, Fukui M, et al: Renal expression of mRNAs for endothelin-l, endothelin-3 and endothelin receptors in NZBAV FI mice. Renal Physiol Biochem 16:233-243, 1993
72. Nakamura T, Ebihara I, Fukui M, et al: Modulation of glomerular endothelin and endothelin receptor gene expression in aminonucleoside-induced nephrosis. J Am Soc Nephrol 5:1585-1590, 1995
73. Theuring F, Schmager F, Thone-Reinicke C, et al: Transgenic mice in endothelin research. Fourth International Conference on Endothelin, April 23-26, 1995, London, UK, P146, 1995 (abstr)
74. Paul M, Schonfelder G, Liefeldt L, Bocker W, Lippoldt A, Zintz M: Renal phenotype in transgenic rats expressing the human endothelin-2 gene. Fourth International Conference on Endothelin, April 23-26, 1995, London, UK P148, 1995 (abstract)
75. Remuzzi A, Ruggenenti P, Mosconi L, et al: Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy. J Nephrol 6:36-43, 1993
76. Fukui M, Nakamura T, Ebihara I, et al: Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli. J Lab Clin Med 123:763-771, 1994
77. Liu X-H, Oldroyd S, Abbate M, et al: Combined administration of ACE inhibitor (ACEi) and angiotensin II receptor antagonist (AII ra) normalizes excessive renal endothelin (ET-1) in rats with passive Heymann nephritis. J Am Soc Nephrol 6:874, 1995 (abstr)
78. Benigni A, Zoja C, Corna D, et al: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 44:440-444, 1993
79. Nakamura T, Ebihara I, Tomino Y, Koide H: Effect of a specific endothelin A receptor antagonist on murine lupus nephritis. Kidney Int 47:481-489, 1995
80. Nakamura T, Ebihara I, Fukui M, et al: Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Diabetes 44:895-899, 1995
81. Terada Y, Tomita K, Nonoguchi H, Marumo F: Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay. J Clin Invest 90:107-112, 1992
82. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 186:867-873, 1992
83. BR) in glomeruli of the remnant kidney. J Am Soc Nephrol 3:438, 1992 (abstr)
84. Benigni A, Zoja C, Coma D, et al: Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney. Am J Kidney Dis (In press)
85. B receptor antagonist improves proteinuria and glomerular lesions in a normotensive rat model of immune complex nephritis. J Am Soc Nephrol 6:866, 1995 (abstr)